IMC 0.00% 7.2¢ immuron limited

Why Isn't Travelan a Nine-Figure Global Market Opportunity?

  1. 928 Posts.
    lightbulb Created with Sketch. 61

    Can anyone explain this to me?  Is it that unreasonable to believe that the only drug known to man today that prevents Shigella and E.Coli. at 90% effectiveness isn't a $100,000,000+ global market opportunity?  Immuron, Gary Jacobs, and company NEED to differentiate Travelan in how it's marketed, because many people including even pharmacists think it's simple bovine colostrum.  It certainly is not, and that sad mistake continues to kill us.  This is a proprietary formulation of hyperimmune bovine colostrum that has been enriched with antigens via vaccination of pregnant cows specifically targeting Shigella and E.Coli.  It is worlds apart from regular old colostrum.


    On Amazon, this critical distinction isn't even apparent.  No one would know the difference.  

    Last edited by Orioles: 19/12/18
 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.000(0.00%)
Mkt cap ! $16.49M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 200000 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 61502 1
View Market Depth
Last trade - 11.35am 13/11/2024 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.